Alpha Teknova, Inc. SEC filings TKNO
Alpha Teknova, Inc. has 222 filings in SEC EDGAR's recent list, going back to Apr 5, 2021. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 16, 2025 | — |
| CORRESP | Letter to the SEC | Jul 14, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2025 | — |
| EFFECT | Filing | Aug 29, 2024 | — |
| CORRESP | Letter to the SEC | Aug 27, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 27, 2024 | — |
| D | Filing | Jul 22, 2024 | — |
| EFFECT | Filing | Nov 7, 2023 | — |
| CORRESP | Letter to the SEC | Nov 3, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 2, 2023 | — |
| D | Filing | Sep 27, 2023 | — |
| EFFECT | Filing | Jul 12, 2022 | — |
| CORRESP | Letter to the SEC | Jul 8, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2022 | — |
| EFFECT | Filing | Jun 24, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 24, 2021 | — |
| CERT | Filing | Jun 24, 2021 | — |
| 8-A12B | Filing | Jun 24, 2021 | — |
| CORRESP | Letter to the SEC | Jun 23, 2021 | — |
| CORRESP | Letter to the SEC | Jun 23, 2021 | — |
| CORRESP | Letter to the SEC | Jun 21, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 8, 2021 | — |
| CORRESP | Letter to the SEC | Jun 4, 2021 | — |
| UPLOAD | Letter from the SEC | May 27, 2021 | — |
| DRSLTR | Filing | May 14, 2021 | — |
| DRS/A | Filing | May 14, 2021 | — |
| UPLOAD | Letter from the SEC | May 4, 2021 | — |
| DRS | Filing | Apr 5, 2021 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- TKNO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hollister, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1850902
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.